The role of atypical pathogens in community-acquired pneumonia.

The atypical pathogens in community-acquired pneumonia traditionally have included Mycoplasma pneumoniae, Chlamydia pneumoniae, and Legionella spp. Recent studies documenting their epidemiology and clinical characteristics have shown that these organisms are indistinguishable from the pneumococcus. Furthermore, therapy no longer depends on the specific bacterial cause of community-acquired pneumonia. Etiologic diagnosis is still difficult, although new methods are becoming available. This article focuses on these issues and on why the term atypical is no longer meaningful.

[1]  P. Edelstein,et al.  Rapid radioimmunoassay diagnosis of Legionnaires' disease: detection and partial characterization of urinary antigen. , 1981, Annals of internal medicine.

[2]  Weinberg An,et al.  Respiratory infections transmitted from animals. , 1991 .

[3]  D J Barnes Microbial etiology of acute pneumonia in hospitalized patients. , 1993, Chest.

[4]  V. Yu,et al.  Legionnaires' disease: new clinical perspective from a prospective pneumonia study. , 1982, The American journal of medicine.

[5]  J. Blanquer,et al.  Aetiology of community acquired pneumonia in Valencia, Spain: a multicentre prospective study. , 1991, Thorax.

[6]  W. Kapoor,et al.  New and Emerging Etiologies for Community‐Acquired Pneumonia with Implications for Therapy: A Prospective Multicenter Study of 359 Cases , 1990, Medicine.

[7]  G. Sarosi Community-acquired fungal diseases. , 1991, Clinics in chest medicine.

[8]  M. Kolczak,et al.  Incidence of community-acquired pneumonia requiring hospitalization. Results of a population-based active surveillance Study in Ohio. The Community-Based Pneumonia Incidence Study Group. , 1997, Archives of internal medicine.

[9]  T. Ishida,et al.  Etiology of community-acquired pneumonia in hospitalized patients: a 3-year prospective study in Japan. , 1998, Chest.

[10]  C. Clancy,et al.  Acute community-acquired pneumonia due to Aspergillus in presumably immunocompetent hosts: clues for recognition of a rare but fatal disease. , 1998, Chest.

[11]  G. Town,et al.  Community acquired pneumonia: aetiology and usefulness of severity criteria on admission. , 1996, Thorax.

[12]  J. Summersgill,et al.  Rapid, sensitive detection of Mycoplasma pneumoniae in simulated clinical specimens by DNA amplification , 1992, Journal of clinical microbiology.

[13]  P. Saikku,et al.  Clinical picture of community-acquired Chlamydia pneumoniae pneumonia requiring hospital treatment: a comparison between chlamydial and pneumococcal pneumonia. , 1996, Thorax.

[14]  A. M. Collier,et al.  Relationships Between Mycoplasma pneumoniae and Human Respiratory Epithelium , 1971, Infection and immunity.

[15]  G. Sarosi,et al.  Azithromycin vs cefuroxime plus erythromycin for empirical treatment of community-acquired pneumonia in hospitalized patients: a prospective, randomized, multicenter trial. , 2000, Archives of internal medicine.

[16]  R. Chanock,et al.  Growth on artificial medium of an agent associated with atypical pneumonia and its identification as a PPLO. , 1962, Proceedings of the National Academy of Sciences of the United States of America.

[17]  F. Ognibene,et al.  The Laboratory Evaluation of Opportunistic Pulmonary Infections , 1996, Annals of Internal Medicine.

[18]  J. Altman,et al.  A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections. , 1986, The New England journal of medicine.

[19]  S. Chevret,et al.  Severe Community-Acquired Pneumonia: Etiology, Epidemiology, and Prognosis Factors , 1994 .

[20]  T. File,et al.  The Radiologic Manifestations of Legionnaire's Disease , 2000 .

[21]  H. Reimann An Acute Infection of the Respiratory Tract With Atypical Pneumonia: A Disease Entity Probably Caused by a Filtrable Virus , 1938 .

[22]  J. Petitjean,et al.  Comparison of two serological methods and a polymerase chain reaction-enzyme immunoassay for the diagnosis of acute respiratory infections with Chlamydia pneumoniae in adults. , 1998, Journal of medical microbiology.

[23]  V L Yu,et al.  Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. American Thoracic Society. Medical Section of the American Lung Association. , 1993 .

[24]  D. Wensley,et al.  Mycoplasma pneumoniae as a cofactor in severe respiratory infections. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[25]  P. Edelstein,et al.  Retrospective evaluation of the Du Pont radioimmunoassay kit for detection of Legionella pneumophila serogroup 1 antigenuria in humans , 1988, Journal of clinical microbiology.

[26]  P. V. Ichinsky,et al.  Causes and Outcomes of the Acute Chest Syndrome in Sickle Cell Disease , 2000 .

[27]  G. Wadell,et al.  Rapid diagnosis of respiratory Chlamydia pneumoniae infection by nested touchdown polymerase chain reaction compared with culture and antigen detection by EIA. , 1997, The Journal of infectious diseases.

[28]  J. Macfarlane An overview of community acquired pneumonia with lessons learned from the British Thoracic Society Study. , 1994, Seminars in respiratory infections.

[29]  G. Sarosi,et al.  Fungal pneumonias. The endemic mycoses. , 1999, Clinics in chest medicine.

[30]  A. Porath,et al.  Mycoplasma pneumoniae community-acquired pneumonia: a review of 101 hospitalized adult patients. , 1996, Respiration; international review of thoracic diseases.

[31]  R. Rodríguez-Roisín,et al.  Severe community-acquired pneumonia. Epidemiology and prognostic factors. , 1991, The American review of respiratory disease.

[32]  J. Alegre,et al.  Legionella pneumophila. A cause of severe community-acquired pneumonia. , 1991, Chest.

[33]  B. Marston,et al.  Surveillance for Legionnaires' disease. Risk factors for morbidity and mortality. , 1994, Archives of internal medicine.

[34]  S. M. Martin,et al.  Legionnaires' Disease: Clinical Features of the Epidemic in Philadelphia , 1979 .

[35]  T. File,et al.  Ofloxacin versus standard therapy in treatment of community-acquired pneumonia requiring hospitalization. Pneumonia Study Group , 1996, Antimicrobial agents and chemotherapy.

[36]  J. Domínguez,et al.  Comparison of the Binax Legionella Urinary Antigen Enzyme Immunoassay (EIA) with the Biotest Legionella Urin Antigen EIA for Detection of Legionella Antigen in both Concentrated and Nonconcentrated Urine Samples , 1998, Journal of Clinical Microbiology.

[37]  L. Ostergaard,et al.  Etiology of community-acquired pneumonia. Evaluation by transtracheal aspiration, blood culture, or serology. , 1993, Chest.

[38]  R. Bhopal Geographical variation of Legionnaires' disease: a critique and guide to future research. , 1993, International journal of epidemiology.

[39]  P. Potgieter,et al.  Etiology and diagnosis of pneumonia requiring ICU admission. , 1992, Chest.

[40]  S. Kahane,et al.  Pneumonia with serological evidence of acute infection with the Chlamydia-like microorganism "Z". , 1997, American journal of respiratory and critical care medicine.

[41]  A. Rolfs,et al.  Chlamydia pneumoniae as a cause of community-acquired pneumonia in hospitalized patients in Berlin. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[42]  G. Gilbert,et al.  Rapid diagnosis of Legionella pneumophila serogroup 1 infection with the Binax enzyme immunoassay urinary antigen test , 1997, Journal of clinical microbiology.

[43]  F. Tenover,et al.  Comparison of cross-staining reactions by Pseudomonas spp. and fluorescein-labeled polyclonal and monoclonal antibodies directed against Legionella pneumophila , 1986, Journal of clinical microbiology.

[44]  A. Porath,et al.  The epidemiology of community-acquired pneumonia among hospitalized adults. , 1997, The Journal of infection.

[45]  A. Porath,et al.  Legionella species community-acquired pneumonia. A review of 56 hospitalized adult patients. , 1996, Chest.

[46]  R. Peeling,et al.  Ambulatory patients with community-acquired pneumonia: the frequency of atypical agents and clinical course. , 1996, The American journal of medicine.

[47]  S. Elberg,et al.  STUDIES ON TUBERCLE BACILLUS-MONOCYTE RELATIONSHIP : I. QUANTITATIVE ANALYSIS OF EFFECT OF SERUM OF ANIMALS VACCINATED WITH BCG UPON BACTERIUM-MONOCYTE SYSTEM , 1956 .

[48]  K. Carroll,et al.  Detection of Legionella Species in Respiratory Specimens Using PCR with Sequencing Confirmation , 2000, Journal of Clinical Microbiology.

[49]  T. File,et al.  Reevaluation of the definition of Legionnaires' disease: use of the urinary antigen assay. Community Based Pneumonia Incidence Study Group. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[50]  J. Bartlett,et al.  GUIDELINES FROM THE INFECTIOUS DISEASES SOCIETY OF AMERICA Community-Acquired Pneumonia in Adults: Guidelines for Management , 1998 .

[51]  J. Bartlett,et al.  Implications for macrolide treatment in community-acquired pneumonia. Hopkins CAP Team. , 1998, Chest.

[52]  陶仲为 Cryptococcal Pneumonia , 2002 .

[53]  D. Kaiser,et al.  Prediction of microbial aetiology at admission to hospital for pneumonia from the presenting clinical features. British Thoracic Society Pneumonia Research Subcommittee. , 1989, Thorax.

[54]  B A Cunha,et al.  Atypical pneumonia. Extrapulmonary clues guide the way to diagnosis. , 1996, Postgraduate medicine.

[55]  G. Harvey,et al.  Multiplex polymerase chain reaction for the simultaneous detection of Mycoplasma pneumoniae, Chlamydia pneumoniae, and Chlamydia psittaci in respiratory samples. , 1999, Journal of clinical pathology.

[56]  J. Rello,et al.  Severe community-acquired pneumonia in the elderly: epidemiology and prognosis. Study Group for Severe Community-Acquired Pneumonia. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[57]  Ch'ien Liu Studies on primary atypical pneumonia. I. Localization, isolation, and cultivation of a virus in chick embryos. , 1957 .

[58]  G. Sarosi 'Atypical pneumonia'. Why this term may be better left unsaid. , 1999, Postgraduate medicine.

[59]  M. Fine,et al.  Quality of care, process, and outcomes in elderly patients with pneumonia. , 1997, JAMA.

[60]  J. Morera,et al.  Detection of Legionella pneumophila serogroup 1 antigen in nonconcentrated urine and urine concentrated by selective ultrafiltration , 1996, Journal of clinical microbiology.

[61]  M. Fine,et al.  Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis. , 1996, JAMA.

[62]  J T Macfarlane,et al.  Comparative clinical and laboratory features of legionella with pneumococcal and mycoplasma pneumonias. , 1987, British journal of diseases of the chest.

[63]  E. Eber,et al.  Rapid detection of Legionella species in bronchoalveolar lavage fluids with the EnviroAmp Legionella PCR amplification and detection kit , 1993, Journal of clinical microbiology.

[64]  D. Podzamczer,et al.  Pneumonia due to Legionella pneumophila and pneumococcal pneumonia: similarities and differences on presentation. , 1989, The European respiratory journal.

[65]  B. Marmion,et al.  Effect of an Organic Gold Salt on Eaton's Primary Atypical Pneumonia Agent and Other Observations , 1961, Nature.

[66]  E. Manor,et al.  Multiple pathogens in adult patients admitted with community-acquired pneumonia: a one year prospective study of 346 consecutive patients. , 1996, Thorax.

[67]  T. File,et al.  A multicenter, randomized study comparing the efficacy and safety of intravenous and/or oral levofloxacin versus ceftriaxone and/or cefuroxime axetil in treatment of adults with community-acquired pneumonia , 1997, Antimicrobial agents and chemotherapy.

[68]  John L. Johnson,et al.  Viral pneumonias , 2000 .

[69]  P. Brachman,et al.  Legionnaires' disease. , 1977, Disease-a-month : DM.

[70]  M. Leinonen Pathogenetic mechanisms and epidemiology of Chlamydia pneumoniae. , 1993, European heart journal.

[71]  D. Schlossberg,et al.  Streptococcus pneumoniae bacteremia in a community hospital. , 1998, Chest.

[72]  J. Macfarlane,et al.  Legionnaires' disease: a review of 79 community acquired cases in Nottingham. , 1986, Thorax.

[73]  K. Waites,et al.  Efficacy of clarithromycin against Mycoplasma pneumoniae. , 1991, The Journal of antimicrobial chemotherapy.

[74]  S. Fischer,et al.  Detection of Legionella by PCR in respiratory specimens using a commercially available kit. , 1998, American Journal of Clinical Pathology.

[75]  J. A. Cuello,et al.  Severe community-acquired pneumonia. Etiology, prognosis, and treatment. , 1990, The American review of respiratory disease.

[76]  D. Murdoch,et al.  Use of the polymerase chain reaction to detect Legionella DNA in urine and serum samples from patients with pneumonia. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[77]  K. Dalhoff,et al.  Chlamydia pneumoniae pneumonia in hospitalized patients. Clinical characteristics and diagnostic value of polymerase chain reaction detection in BAL. , 1996, Chest.

[78]  R. Snijder,et al.  Evaluation of PCR, Culture, and Serology for Diagnosis of Chlamydia pneumoniae Respiratory Infections , 1998, Journal of Clinical Microbiology.

[79]  C. Feldman,et al.  The aetiology of severe community-acquired pneumonia and its impact on initial, empiric, antimicrobial chemotherapy. , 1995, Respiratory medicine.

[80]  Richard D Moore,et al.  Community-acquired pneumonia: impact of immune status. , 1995 .

[81]  L. Campbell,et al.  Detection of Chlamydia pneumoniae by polymerase chain reaction , 1992, Journal of clinical microbiology.

[82]  H. Goossens,et al.  Detection of Mycoplasma pneumoniae by two polymerase chain reactions and role of M. pneumoniae in acute respiratory tract infections in pediatric patients. , 1996, The Journal of infectious diseases.

[83]  S. Norrby Atypical pneumonia in the Nordic countries: aetiology and clinical results of a trial comparing fleroxacin and doxycycline. Nordic Atypical Pneumonia Study Group. , 1997 .

[84]  G. Kenny,et al.  Mycoplasma pneumoniae pneumonia in an urban area. Five years of surveillance. , 1970 .

[85]  G. Sarosi,et al.  Evaluation of the Winthrop-University Hospital criteria to identify Legionella pneumonia. , 2001, Chest.

[86]  F. Blasi,et al.  Severe community-acquired pneumonia: a possible role for Chlamydia pneumoniae. , 1996, Respiration; international review of thoracic diseases.

[87]  J. Heesemann,et al.  Molecular Approaches to Diagnosis of Pulmonary Diseases Due toMycoplasma pneumoniae , 1998, Journal of Clinical Microbiology.

[88]  M. Kolczak,et al.  Incidence of Community-Acquired Pneumonia Requiring Hospitalization Results of a Population-Based Active Surveillance Study in Ohio , 1997 .

[89]  J. Bonnet,et al.  Detection of Mycoplasma pneumoniae by using the polymerase chain reaction , 1989 .

[90]  P. W. Wertheim-van Dillen,et al.  Performance of Meridian ImmunoCard Mycoplasma Test in a multicenter clinical trial , 1996, Journal of clinical microbiology.

[91]  C. Broome,et al.  Fatal nosocomial Legionnaires' disease: clinical and epidemiologic characteristics. , 1979, Annals of internal medicine.

[92]  J. Morera,et al.  Comparative study of the clinical presentation of Legionella pneumonia and other community-acquired pneumonias. , 1998, Chest.

[93]  B. Cunha Clinical features of legionnaires' disease. , 1998, Seminars in respiratory infections.

[94]  P. Saikku,et al.  Pneumonia due to Chlamydia pneumoniae: prevalence, clinical features, diagnosis, and treatment. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[95]  T. File,et al.  The role of atypical pathogens: Mycoplasma pneumoniae, Chlamydia pneumoniae, and Legionella pneumophila in respiratory infection. , 1998, Infectious disease clinics of North America.

[96]  R. Estruch,et al.  Community-acquired pneumonia in the elderly. Clinical and nutritional aspects. , 1997, American journal of respiratory and critical care medicine.

[97]  J. Ramirez,et al.  Diagnosis of Legionella pneumophila, Mycoplasma pneumoniae, or Chlamydia pneumoniae lower respiratory infection using the polymerase chain reaction on a single throat swab specimen. , 1996, Diagnostic microbiology and infectious disease.

[98]  M. D. Eaton,et al.  STUDIES ON THE ETIOLOGY OF PRIMARY ATYPICAL PNEUMONIA , 1945, The Journal of experimental medicine.